Feasibility study to treat lung cancer with the permanently implantable LDR CivaSheet

Brief description of study

If you have been diagnosed with non-smail cell lung cancer (NSCLC), you may qualify for this study evaluating the usefulness of the brachytherapy source - CivaSheet®. The main goal of this study is to evaluate the usefulness of a brachytherapy device (the insertion of radioactive implants into the tissue) which is designed to deliver the radiation source targeted directly to the tumor.


Clinical Study Identifier: s17-01418
ClinicalTrials.gov Identifier: NCT03290534


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.